Atazanavir

In the US, Atazanavir (atazanavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

• Atazanavir
• Atazanavir and cobicistat
• Atazanavir Capsules
• Atazanavir Powder for Oral Suspension
• Atazanavir Sulfate
• Atazanavir

UK matches:

• Atazanavir Mylan
• ATAZANAVIR TEVA 150 MG CAPSULES HARD (Leaflet)
• ATAZANAVIR TEVA 200 MG CAPSULES HARD (Leaflet)
• ATAZANAVIR TEVA 300 MG CAPSULES HARD (Leaflet)
• ATAZANAVIR ZENTIVA 150 MG HARD CAPSULES (Leaflet)
• ATAZANAVIR ZENTIVA 200 MG HARD CAPSULES (Leaflet)
• ATAZANAVIR ZENTIVA 300 MG HARD CAPSULES (Leaflet)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE08

CAS registry number (Chemical Abstracts Service)

0198904-31-3

Chemical Formula

C38-H52-N6-O7

Molecular Weight

704

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Chemical Names

(3S,8S,9S,12S)-3,12-bis(1,1-dimetyletyl)-8-hydoxy-4,11-dioxo-9-(phenylmetyl)-6-((4-(2-pyridinyl)phenyl)metyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimetyl ester

(S)-{1-[N'-[(2S,3S)-2-Hydroxy-3-((S-metoxycarbonylamino-3,3-dimetylbutyrylamino)-4- phenylbutyl]-N'-(4-pyridin-2-ylbenzyl)hydrazinocarbonyl]-2,2-dimetehyletylpropyl} carbaminsäuremetylester (IUPAC)

Dimetyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate (WHO, BAN)

Foreign Names

• Atazanavirum (Latin)
• Atazanavir (German)
• Atazanavir (French)
• Atazanavir (Spanish)

Generic Names

• Atazanavir (OS: BAN)
• BMS 232632 (IS: Bristol-Myers)
• CGP 73547 (IS: Novartis)
• Latazanavir (IS)
• UNII-QZU4H47A3S (IS)
• Zrivida (IS)
• Atazanavir Sulfate (OS: USAN, BANM, JAN)
• BMS-232632-05 (IS: Bristol-Myers)
• UNII-4MT4VIE29P (IS)

Brand Names

• Anzavir-R (Atazanavir and Ritonavir)
  Mylan, India
• Atazor
  Emcure, India
• Evotaz (Atazanavir and Cobicistat)
  Bristol-Myers Squibb, United States
• Reyataz
  Bristol Myers Squibb, Chile; Bristol-M.S., Argentina; Bristol-Myers Squibb, Mexico
• Synthivan (Atazanavir and Ritonavir)
  Cipla, India
• Virataz
  Hetero, India
• Virataz-R (Atazanavir and Ritonavir)
  Hetero, India
• Aspen Atazanavir
  Pharmacare, South Africa
• Atazanavir Humax
  Humax Pharmaceutical, Colombia
• Atazor
  Emcure, South Africa
• Evotaz (Atazanavir and Cobicistat)
  Bristol-Myers Squibb Pharmaceutical, United Kingdom
• Reyataz
  Abeefe Bristol-Myers Squibb, Peru; Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Bristol-Myers Squibb Pharmaceuticals, Austria; Haemato Pharm, Austria; Inopha, Austria

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.